Loading clinical trials...

Technology Assisted Programs That Promote Mental Health for Teenagers | Clinical Trials | Clareo Health

COMPLETEDNA

Technology Assisted Programs That Promote Mental Health for Teenagers

Technology Assisted Intervention for the Treatment and Prevention of Depression

NCT01912729•Northwestern University

Summary

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly behavioral intervention technologies (BITs) for the prevention of depression in adolescents. The investigators define BITs as interventions that use information and telecommunications technologies such as the internet, mobile or traditional phones, computers and/or other technologies to support and deliver psychological and behavioral interventions. Through usability testing, focus interviews, and field trials, investigators may modify the technologies and intervention based on immediate usage data.

Detailed Description

Eligibility

Age

14 - 19 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Has a score of 12-39 (males) / 15-39 (females) on the Center for Epidemiologic Studies Depression Scale (CES-D) OR reported past month use of marijuana, cigarettes, alcohol or other substances on the Center for Disease Control Youth Risk Behavior Survey (YRBS).
•Is familiar with the use of computers and the Internet, as well as mobile phones
•Is able to speak and read English
•Is between 14-19 years of age

Exclusion Criteria

•Is currently taking an antidepressant medication or has taken one in the previous 3 months
•Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of the Internet or mobile phone
•Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance dependence, or other diagnosis for which participation in this trial is either inappropriate or dangerous. Inclusion of participants with symptoms of anxiety disorders, eating disorders and substance abuse disorders will be made on a case-by-case basis.
•Is severely suicidal (has ideation, plan, and intent in the past 12 months) .

Locations (1)

Northwestern University

Chicago, Illinois, United States

Key Dates

Start Date

January 1, 2016

Primary Completion Date

June 1, 2016

Completion Date

July 1, 2016

Last Updated

December 13, 2018

Enrollment

ACTUAL participants

Conditions

Depression

Interventions

Networked Peer Support with Peer Guide

BEHAVIORAL

Networked Peer Support with Clinician Coach

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 13, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Technology Assisted Programs That Promote Mental Health for Teenagers

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures